276 related articles for article (PubMed ID: 35777502)
21. The Delta SARS-CoV-2 Variant of Concern Induces Distinct Pathogenic Patterns of Respiratory Disease in K18-hACE2 Transgenic Mice Compared to the Ancestral Strain from Wuhan.
Liu X; Mostafavi H; Ng WH; Freitas JR; King NJC; Zaid A; Taylor A; Mahalingam S
mBio; 2022 Jun; 13(3):e0068322. PubMed ID: 35420469
[TBL] [Abstract][Full Text] [Related]
22. COVID-19: Discovery, diagnostics and drug development.
Asselah T; Durantel D; Pasmant E; Lau G; Schinazi RF
J Hepatol; 2021 Jan; 74(1):168-184. PubMed ID: 33038433
[TBL] [Abstract][Full Text] [Related]
23. Molecular Basis of Pathogenesis of Coronaviruses: A Comparative Genomics Approach to Planetary Health to Prevent Zoonotic Outbreaks in the 21st Century.
Asrani P; Hasan GM; Sohal SS; Hassan MI
OMICS; 2020 Nov; 24(11):634-644. PubMed ID: 32940573
[TBL] [Abstract][Full Text] [Related]
24. Management of epigenomic networks entailed in coronavirus infections and COVID-19.
El Baba R; Herbein G
Clin Epigenetics; 2020 Aug; 12(1):118. PubMed ID: 32758273
[TBL] [Abstract][Full Text] [Related]
25. Characterization of MW06, a human monoclonal antibody with cross-neutralization activity against both SARS-CoV-2 and SARS-CoV.
Jiang W; Wang J; Jiao S; Gu C; Xu W; Chen B; Wang R; Chen H; Xie Y; Wang A; Li G; Zeng D; Zhang J; Zhang M; Wang S; Wang M; Gui X
MAbs; 2021; 13(1):1953683. PubMed ID: 34313527
[TBL] [Abstract][Full Text] [Related]
26. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
Stratton CW; Tang YW; Lu H
J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
[TBL] [Abstract][Full Text] [Related]
27. Perspectives for repurposing drugs for the coronavirus disease 2019.
Cherian SS; Agrawal M; Basu A; Abraham P; Gangakhedkar RR; Bhargava B
Indian J Med Res; 2020 Feb & Mar; 151(2 & 3):160-171. PubMed ID: 32317408
[TBL] [Abstract][Full Text] [Related]
28. Quantitative Insight into Immunopathology of SARS-CoV-2 Infection.
Soni B; Kabra R; Singh S
J Interferon Cytokine Res; 2021 Jul; 41(7):244-257. PubMed ID: 34280026
[TBL] [Abstract][Full Text] [Related]
29. Epigenetic Control of Innate Immunity: Consequences of Acute Respiratory Virus Infection.
Lefkowitz RB; Miller CM; Martinez-Caballero JD; Ramos I
Viruses; 2024 Jan; 16(2):. PubMed ID: 38399974
[TBL] [Abstract][Full Text] [Related]
30. Global Emergence of SARS-CoV2 Infection and Scientific Interventions to Contain its Spread.
Ajmera H; Lakhawat SS; Malik N; Kumar A; Bhatti JS; Kumar V; Gogoi H; Jaswal SK; Chandel S; Sharma PK
Curr Protein Pept Sci; 2024; 25(4):307-325. PubMed ID: 38265408
[TBL] [Abstract][Full Text] [Related]
31. A Comprehensive Review of COVID-19 Virology, Vaccines, Variants, and Therapeutics.
Forchette L; Sebastian W; Liu T
Curr Med Sci; 2021 Dec; 41(6):1037-1051. PubMed ID: 34241776
[TBL] [Abstract][Full Text] [Related]
32. Characterization of SARS-CoV-2 Evasion: Interferon Pathway and Therapeutic Options.
Znaidia M; Demeret C; van der Werf S; Komarova AV
Viruses; 2022 Jun; 14(6):. PubMed ID: 35746718
[TBL] [Abstract][Full Text] [Related]
33. The novel zoonotic COVID-19 pandemic: An expected global health concern.
Contini C; Di Nuzzo M; Barp N; Bonazza A; De Giorgio R; Tognon M; Rubino S
J Infect Dev Ctries; 2020 Mar; 14(3):254-264. PubMed ID: 32235085
[TBL] [Abstract][Full Text] [Related]
34. Epigenetic Mechanisms Underlying COVID-19 Pathogenesis.
Kaneko S; Takasawa K; Asada K; Shinkai N; Bolatkan A; Yamada M; Takahashi S; Machino H; Kobayashi K; Komatsu M; Hamamoto R
Biomedicines; 2021 Sep; 9(9):. PubMed ID: 34572329
[TBL] [Abstract][Full Text] [Related]
35. Similarities and Dissimilarities of COVID-19 and Other Coronavirus Diseases.
Fung TS; Liu DX
Annu Rev Microbiol; 2021 Oct; 75():19-47. PubMed ID: 33492978
[TBL] [Abstract][Full Text] [Related]
36. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review.
Wiersinga WJ; Rhodes A; Cheng AC; Peacock SJ; Prescott HC
JAMA; 2020 Aug; 324(8):782-793. PubMed ID: 32648899
[TBL] [Abstract][Full Text] [Related]
37. Potential health benefits of zinc supplementation for the management of COVID-19 pandemic.
Oyagbemi AA; Ajibade TO; Aboua YG; Gbadamosi IT; Adedapo ADA; Aro AO; Adejumobi OA; Thamahane-Katengua E; Omobowale TO; Falayi OO; Oyagbemi TO; Ogunpolu BS; Hassan FO; Ogunmiluyi IO; Ola-Davies OE; Saba AB; Adedapo AA; Nkadimeng SM; McGaw LJ; Kayoka-Kabongo PN; Oguntibeju OO; Yakubu MA
J Food Biochem; 2021 Feb; 45(2):e13604. PubMed ID: 33458853
[TBL] [Abstract][Full Text] [Related]
38. Genetic variation analyses indicate conserved SARS-CoV-2-host interaction and varied genetic adaptation in immune response factors in modern human evolution.
Lee JW; Lee IH; Sato T; Kong SW; Iimura T
Dev Growth Differ; 2021 Apr; 63(3):219-227. PubMed ID: 33595856
[TBL] [Abstract][Full Text] [Related]
39. Coronaviral Infection and Interferon Response: The Virus-Host Arms Race and COVID-19.
Liu Q; Chi S; Dmytruk K; Dmytruk O; Tan S
Viruses; 2022 Jun; 14(7):. PubMed ID: 35891331
[TBL] [Abstract][Full Text] [Related]
40. TMPRSS2 and RNA-Dependent RNA Polymerase Are Effective Targets of Therapeutic Intervention for Treatment of COVID-19 Caused by SARS-CoV-2 Variants (B.1.1.7 and B.1.351).
Lee J; Lee J; Kim HJ; Ko M; Jee Y; Kim S
Microbiol Spectr; 2021 Sep; 9(1):e0047221. PubMed ID: 34378968
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
